vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and MGIC INVESTMENT CORP (MTG). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $297.1M, roughly 1.7× MGIC INVESTMENT CORP). MGIC INVESTMENT CORP runs the higher net margin — 55.6% vs 6.8%, a 48.8% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -3.0%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -1.4%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
MGIC Investment Corporation NYSE: MTG ("MGIC") is a provider of private mortgage insurance in the United States. The company is headquartered in Milwaukee, Wisconsin.
MD vs MTG — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $297.1M |
| Net Profit | $33.7M | $165.3M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | — |
| Net Margin | 6.8% | 55.6% |
| Revenue YoY | -1.7% | -3.0% |
| Net Profit YoY | 10.5% | -10.9% |
| EPS (diluted) | $0.40 | $0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $297.1M | ||
| Q4 25 | $493.8M | $298.7M | ||
| Q3 25 | $492.9M | $304.5M | ||
| Q2 25 | $468.8M | $304.2M | ||
| Q1 25 | $458.4M | $306.2M | ||
| Q4 24 | $502.4M | $301.4M | ||
| Q3 24 | $511.2M | $306.6M | ||
| Q2 24 | $504.3M | $305.3M |
| Q1 26 | — | $165.3M | ||
| Q4 25 | $33.7M | $169.3M | ||
| Q3 25 | $71.7M | $191.1M | ||
| Q2 25 | $39.3M | $192.5M | ||
| Q1 25 | $20.7M | $185.5M | ||
| Q4 24 | $30.5M | $184.7M | ||
| Q3 24 | $19.4M | $200.0M | ||
| Q2 24 | $-153.0M | $204.2M |
| Q1 26 | — | — | ||
| Q4 25 | 9.9% | 71.2% | ||
| Q3 25 | 13.8% | 77.2% | ||
| Q2 25 | 12.8% | 80.9% | ||
| Q1 25 | 7.0% | 76.6% | ||
| Q4 24 | 7.8% | 77.9% | ||
| Q3 24 | 6.6% | 82.9% | ||
| Q2 24 | -31.3% | 85.1% |
| Q1 26 | — | 55.6% | ||
| Q4 25 | 6.8% | 56.7% | ||
| Q3 25 | 14.5% | 62.8% | ||
| Q2 25 | 8.4% | 63.3% | ||
| Q1 25 | 4.5% | 60.6% | ||
| Q4 24 | 6.1% | 61.3% | ||
| Q3 24 | 3.8% | 65.2% | ||
| Q2 24 | -30.3% | 66.9% |
| Q1 26 | — | $0.76 | ||
| Q4 25 | $0.40 | $0.75 | ||
| Q3 25 | $0.84 | $0.83 | ||
| Q2 25 | $0.46 | $0.81 | ||
| Q1 25 | $0.24 | $0.75 | ||
| Q4 24 | $0.37 | $0.71 | ||
| Q3 24 | $0.23 | $0.77 | ||
| Q2 24 | $-1.84 | $0.77 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $235.1M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $5.0B |
| Total Assets | $2.2B | $6.4B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $235.1M | ||
| Q4 25 | $375.2M | $369.0M | ||
| Q3 25 | $340.1M | $266.9M | ||
| Q2 25 | $224.7M | $294.9M | ||
| Q1 25 | $99.0M | $207.0M | ||
| Q4 24 | $229.9M | $229.5M | ||
| Q3 24 | $103.8M | $288.6M | ||
| Q2 24 | $19.4M | $281.8M |
| Q1 26 | — | — | ||
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $5.0B | ||
| Q4 25 | $865.9M | $5.1B | ||
| Q3 25 | $890.7M | $5.2B | ||
| Q2 25 | $833.8M | $5.2B | ||
| Q1 25 | $789.2M | $5.1B | ||
| Q4 24 | $764.9M | $5.2B | ||
| Q3 24 | $732.5M | $5.3B | ||
| Q2 24 | $706.5M | $5.1B |
| Q1 26 | — | $6.4B | ||
| Q4 25 | $2.2B | $6.6B | ||
| Q3 25 | $2.2B | $6.6B | ||
| Q2 25 | $2.1B | $6.5B | ||
| Q1 25 | $2.0B | $6.5B | ||
| Q4 24 | $2.2B | $6.5B | ||
| Q3 24 | $2.1B | $6.7B | ||
| Q2 24 | $2.0B | $6.5B |
| Q1 26 | — | — | ||
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $114.1M | $230.8M | ||
| Q3 25 | $137.3M | $215.4M | ||
| Q2 25 | $137.2M | $183.0M | ||
| Q1 25 | $-117.5M | $223.7M | ||
| Q4 24 | $133.0M | $182.4M | ||
| Q3 24 | $91.8M | $182.9M | ||
| Q2 24 | $107.0M | $169.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | $230.2M | ||
| Q3 25 | — | $215.1M | ||
| Q2 25 | — | $183.0M | ||
| Q1 25 | — | $223.5M | ||
| Q4 24 | — | $181.9M | ||
| Q3 24 | — | $182.5M | ||
| Q2 24 | — | $169.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 77.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 60.1% | ||
| Q1 25 | — | 73.0% | ||
| Q4 24 | — | 60.3% | ||
| Q3 24 | — | 59.5% | ||
| Q2 24 | — | 55.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | 3.39× | 1.36× | ||
| Q3 25 | 1.91× | 1.13× | ||
| Q2 25 | 3.49× | 0.95× | ||
| Q1 25 | -5.66× | 1.21× | ||
| Q4 24 | 4.36× | 0.99× | ||
| Q3 24 | 4.72× | 0.91× | ||
| Q2 24 | — | 0.83× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
MTG
Segment breakdown not available.
